Practice Management
Feature
Cardiologist sues hospital, claims he was fired in retaliation
Lawsuit alleges that the defendants “placed profit above all else.”
Commentary
Why doctors are losing trust in patients; what should be done?
There’s a large amount of literature about what makes patients trust their doctor.
Commentary
No, you can’t see a different doctor: We need zero tolerance of patient bias
While speech may not constitute violence in the strictest sense of the word, there is growing evidence that it can be physically harmful.
Feature
States cracking down harder on docs who sexually abuse patients
The Federation of State Medical Boards conducted a 2-year review of how medical boards handled cases of sexual misconduct.
Coding
Advocacy Update: Ringing in 2023
We review the new digital pathology codes released on July 1, 2022, that will go into effect January 1, 2023. We also discuss the proposed...
Feature
Employers use patient assistance programs to offset their own costs
Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for...
Feature
Florida doc dies by suicide after allegedly drugging and raping patients
A Collier County Sheriff’s deputy found the internist’s body near his Naples home with a gunshot...
Latest News
Women docs: How your next job contract can reflect your real goals
“I found that navigating contracts from the standpoint of a woman still in childbearing years was a little disappointing and challenging,”
Feature
How blunt is too blunt for informed consent?
There’s a fine line between providing enough information on the risks and benefits of a particular treatment and knowing you’ve explained it well...
From the Journals
Analysis of doctors’ EHR email finds infrequent but notable hostility
Researchers were struck by the hostility of negative sentiment in some emails to physicians.
From the Journals
U.S. biosimilar competition, use, and availability still lags behind European countries
Greater marketing and uptake of biosimilars in Germany and Switzerland promoted lower drug costs, compared with the United States.